MOESM2 of Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)
Additional file 2. Questions and choices in Oral Hypoglycemic Agent-Questionnaire (OHA-Q) ver.2. The data on this file consist of the questions and choices in the Oral Hypoglycemic Agent-Questionnaire (OHA-Q) ver.2